Will Circulating Tumor DNA Help Predict HPV-Related Throat Cancer? - Takeaways - MDSpire

Will Circulating Tumor DNA Help Predict HPV-Related Throat Cancer?

A Keck Medicine of USC head and neck surgeon discusses circulating HPV DNA as a biomarker that could help make more individualized treatment decisions.

  • March 24, 2026

  • 5 min

Share

  • 1

    Circulating HPV DNA (HPV ctDNA) is being investigated as a potential biomarker for predicting HPV-related throat cancer.

  • 2

    Initial studies indicate that HPV ctDNA levels in blood correlate with disease burden, aiding in treatment response assessment.

  • 3

    HPV ctDNA testing could provide a minimally invasive method to monitor cancer presence before, during, and after treatment.

  • 4

    More research is needed to validate HPV ctDNA as a reliable biomarker and to establish standardized testing methods.

  • 5

    The integration of HPV ctDNA tests may enhance personalized treatment plans, reducing unnecessary therapies and toxicities.

Original Source(s)

Will Circulating Tumor DNA Help Predict HPV-Related Throat Cancer?

  • March 24, 2026

Related Content

Dana-Farber Research News 05.15.2026

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from April 16 - 30.

  • May 15, 2026

  • 21 min
Advancing early detection during Head and Neck Cancer Awareness Month

April is Head and Neck Cancer Awareness Month, highlighting a diverse group of diseases that account for nearly 5% of all cancers in the United States.

  • April 8, 2026

  • 1 min
Tracing Metabolic Inflexibility in Fanconi Anemia 

Stable-isotope glucose tracing reveals impaired fuel switching and altered energy use in a rare DNA-repair disorder